Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study

Trevor J. Orchard, Wanjie Sun, Patricia A. Cleary, Saul M. Genuth, John M. Lachin, Paula McGee, Andrew D. Paterson, Philip Raskin, Yefim Anbinder, Andrew P. Levy

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Many patients with type 1 diabetes develop renal disease despite moderately good metabolic control, suggesting other risk factors may play a role. Recent evidence suggests that the haptoglobin (HP) 2-2 genotype, which codes for a protein with reduced antioxidant activity, may predict renal function decline in type 1 diabetes. We examined this hypothesis in 1,303 Caucasian participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. HP genotype was determined by polyacrylamide gel electrophoresis. Glomerular filtration rate was estimated by the Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation and albumin excretion based on timed urine samples. Participants were followed up for a mean of 22 years. HP genotype was significantly associated with the development of sustained estimated glomerular filtration rate (GFR) <60 mL/min/1.73 m2 and with end-stage renal disease (ESRD), with HP 2-2 having greater risk than HP 2-1 and 1-1. No association was seen with albuminuria. Although there was no treatment group interaction, the associations were only significant in the conventional treatment group, where events rates were much higher. We conclude that the HP genotype is significantly associated with the development of reduced GFR and ESRD in the DCCT/EDIC study.

Original languageEnglish (US)
Pages (from-to)3218-3223
Number of pages6
JournalDiabetes
Volume62
Issue number9
DOIs
StatePublished - Sep 2013

Fingerprint

Haptoglobins
Diabetes Complications
Epidemiology
Genotype
Kidney
Glomerular Filtration Rate
Type 1 Diabetes Mellitus
Chronic Kidney Failure
Albuminuria
Chronic Renal Insufficiency
Polyacrylamide Gel Electrophoresis
Albumins
Antioxidants
Urine
Therapeutics
Proteins

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. / Orchard, Trevor J.; Sun, Wanjie; Cleary, Patricia A.; Genuth, Saul M.; Lachin, John M.; McGee, Paula; Paterson, Andrew D.; Raskin, Philip; Anbinder, Yefim; Levy, Andrew P.

In: Diabetes, Vol. 62, No. 9, 09.2013, p. 3218-3223.

Research output: Contribution to journalArticle

Orchard, Trevor J. ; Sun, Wanjie ; Cleary, Patricia A. ; Genuth, Saul M. ; Lachin, John M. ; McGee, Paula ; Paterson, Andrew D. ; Raskin, Philip ; Anbinder, Yefim ; Levy, Andrew P. / Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. In: Diabetes. 2013 ; Vol. 62, No. 9. pp. 3218-3223.
@article{db30d3061afe4b0ab2b8dd53fe6c5b3c,
title = "Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study",
abstract = "Many patients with type 1 diabetes develop renal disease despite moderately good metabolic control, suggesting other risk factors may play a role. Recent evidence suggests that the haptoglobin (HP) 2-2 genotype, which codes for a protein with reduced antioxidant activity, may predict renal function decline in type 1 diabetes. We examined this hypothesis in 1,303 Caucasian participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. HP genotype was determined by polyacrylamide gel electrophoresis. Glomerular filtration rate was estimated by the Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation and albumin excretion based on timed urine samples. Participants were followed up for a mean of 22 years. HP genotype was significantly associated with the development of sustained estimated glomerular filtration rate (GFR) <60 mL/min/1.73 m2 and with end-stage renal disease (ESRD), with HP 2-2 having greater risk than HP 2-1 and 1-1. No association was seen with albuminuria. Although there was no treatment group interaction, the associations were only significant in the conventional treatment group, where events rates were much higher. We conclude that the HP genotype is significantly associated with the development of reduced GFR and ESRD in the DCCT/EDIC study.",
author = "Orchard, {Trevor J.} and Wanjie Sun and Cleary, {Patricia A.} and Genuth, {Saul M.} and Lachin, {John M.} and Paula McGee and Paterson, {Andrew D.} and Philip Raskin and Yefim Anbinder and Levy, {Andrew P.}",
year = "2013",
month = "9",
doi = "10.2337/db13-0256",
language = "English (US)",
volume = "62",
pages = "3218--3223",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "9",

}

TY - JOUR

T1 - Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study

AU - Orchard, Trevor J.

AU - Sun, Wanjie

AU - Cleary, Patricia A.

AU - Genuth, Saul M.

AU - Lachin, John M.

AU - McGee, Paula

AU - Paterson, Andrew D.

AU - Raskin, Philip

AU - Anbinder, Yefim

AU - Levy, Andrew P.

PY - 2013/9

Y1 - 2013/9

N2 - Many patients with type 1 diabetes develop renal disease despite moderately good metabolic control, suggesting other risk factors may play a role. Recent evidence suggests that the haptoglobin (HP) 2-2 genotype, which codes for a protein with reduced antioxidant activity, may predict renal function decline in type 1 diabetes. We examined this hypothesis in 1,303 Caucasian participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. HP genotype was determined by polyacrylamide gel electrophoresis. Glomerular filtration rate was estimated by the Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation and albumin excretion based on timed urine samples. Participants were followed up for a mean of 22 years. HP genotype was significantly associated with the development of sustained estimated glomerular filtration rate (GFR) <60 mL/min/1.73 m2 and with end-stage renal disease (ESRD), with HP 2-2 having greater risk than HP 2-1 and 1-1. No association was seen with albuminuria. Although there was no treatment group interaction, the associations were only significant in the conventional treatment group, where events rates were much higher. We conclude that the HP genotype is significantly associated with the development of reduced GFR and ESRD in the DCCT/EDIC study.

AB - Many patients with type 1 diabetes develop renal disease despite moderately good metabolic control, suggesting other risk factors may play a role. Recent evidence suggests that the haptoglobin (HP) 2-2 genotype, which codes for a protein with reduced antioxidant activity, may predict renal function decline in type 1 diabetes. We examined this hypothesis in 1,303 Caucasian participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. HP genotype was determined by polyacrylamide gel electrophoresis. Glomerular filtration rate was estimated by the Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation and albumin excretion based on timed urine samples. Participants were followed up for a mean of 22 years. HP genotype was significantly associated with the development of sustained estimated glomerular filtration rate (GFR) <60 mL/min/1.73 m2 and with end-stage renal disease (ESRD), with HP 2-2 having greater risk than HP 2-1 and 1-1. No association was seen with albuminuria. Although there was no treatment group interaction, the associations were only significant in the conventional treatment group, where events rates were much higher. We conclude that the HP genotype is significantly associated with the development of reduced GFR and ESRD in the DCCT/EDIC study.

UR - http://www.scopus.com/inward/record.url?scp=84887517355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887517355&partnerID=8YFLogxK

U2 - 10.2337/db13-0256

DO - 10.2337/db13-0256

M3 - Article

C2 - 23761102

AN - SCOPUS:84887517355

VL - 62

SP - 3218

EP - 3223

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 9

ER -